StockData
GLUCOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31

Glucose Health, Inc.

Financials through Q3 FY2017, quarter ended Sep 30, 2017Last filing: 10-Q on Nov 14, 2017
$0.44+0.10 (+28.76%)

Close on Oct 19, 2026

Market cap
$1.82M
P/E (TTM)
–
Dividend yield
–

Earnings

Quarterly results announced on Form 8-K, Item 2.02

No earnings releases found

Glucose Health has not filed an earnings release (Form 8-K, Item 2.02) that we could match to a fiscal quarter.

Press releases

Announcements Glucose Health filed with the SEC

  • FORM 8-K

    Event dated Apr 6, 2017, from SEC EDGAR

  • FORM 8-K

    Event dated Jan 6, 2016, from SEC EDGAR

  • FORM 8-K

    Event dated Feb 5, 2016, from SEC EDGAR

  • FORM 8-K

    Event dated Jan 27, 2016, from SEC EDGAR

  • FORM 8-K

    Event dated Jun 30, 2015, from SEC EDGAR

  • FORM 8-K

    Event dated Feb 10, 2015, from SEC EDGAR

  • FORM 8-K

    Event dated Dec 15, 2014, from SEC EDGAR

  • FORM 8-K

    Event dated Nov 5, 2014, from SEC EDGAR

  • FORM 8-K

    Event dated Oct 3, 2014, from SEC EDGAR

  • FORM 8-K

    Event dated Oct 1, 2014, from SEC EDGAR

  • FORM 8-K

    Event dated Jul 22, 2014, from SEC EDGAR

  • FORM 8-K

    Event dated Apr 30, 2014, from SEC EDGAR

  • FORM 8-K

    Event dated Apr 21, 2014, from SEC EDGAR

  • FORM 8-K

    Event dated Dec 19, 2013, from SEC EDGAR

  • FORM 8-K

    Event dated Aug 1, 2013, from SEC EDGAR